Skip to content
Home/Companies/Pharma/Duopharm

Duopharm

Pharma·Senegal·Exited 2016·Held 6yr
Entry
2010
Hold
6yr
Exit
2016

Who owns Duopharm?

Duopharm was owned by Investisseurs et Partenaires through IPDEV 1 (2002 vintage) from 2010 to 2016.

Hand-verified · updated 2026-08-11

Investisseurs et Partenaires
Investor
Investisseurs et Partenaires
IPDEV 1 · 2002 · Growth

Key facts

HQSenegal
SectorPharma
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2016

More from IPDEV 1

Other portfolio companies in the same fund.

Normat
Exited 2021
IndustrialsBenin· 2017
Nutrizaza
Exited 2017
ConsumerMadagascar· 2012
CDS
Exited 2016
EnergyMauritania· 2011
Fides Microfinance Senegal
Exited 2018
FinancialsSenegal· 2011
to
Fides Bank Namibia
Exited 2014
FinancialsNamibia· 2010
to
Trainis
Active
EducationMali· 2010

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
IRAB
IRAB
Active
ARCHIMEDSpain· 2026
Track Duopharm

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Duopharm.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue